Skip to Content
Merck
  • Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis.

Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis.

Experimental and therapeutic medicine (2019-04-17)
Daniela Cristea, Marius Trandafir, Violeta Claudia Bojinca, Adriana Simona Ciontea, Melania Mihaela Andrei, Andrei Popa, Brandusa Elena Lixandru, Cornelia Madalina Militaru, Alexandra Maria Nascutiu, Denisa Predeteanu, Ruxandra Ionescu, Claudiu Popescu, Ani Ioana Cotar, Mircea Ioan Popa, Demetrios A Spandidos, Irina Codita
ABSTRACT

Spondyloarthritis (SpA) is a group of associated chronic systemic inflammatory immune-mediated rheumatic diseases affecting axial and peripheral joints and entheses. The aim of the present study was to identify what parameters are useful to determine in order to better understand the correlation between the disease activity/severity and the microbiological results/immune status against intestinal and/or urogenital pathogens. Microorganisms known to trigger SpA, including Klebsiella spp., Yersinia spp., Salmonella spp., Campylobacter spp. and Chlamydia spp., were analyzed in various specimens (stool, urine, synovial fluid and serum) collected from 27 randomly selected SpA patients and 26 healthy controls using a combined direct and indirect approach relying on conventional culture technique and nucleic acid-based assays together with serological testing by ELISA. Although Escherichia coli derived from phylogroup A prevailed in the gut microflora of the patients and controls, differences were observed regarding the representatives of the other phylogroups with a higher prevalence of E.coli members of phylogenetic group B1 in the stool specimens of patients. Antibodies against the targeted species were detected in SpA patients and controls, and the serological profiles of the former were more diverse and complex. In conclusion, the detection of anti-bacterial antibodies combined with other specific laboratory investigations should be more extensively used to monitor SpA patients in association with their symptoms and in order to determine and administer more effective therapeutics.